Geoffrey Lee1,2, Patricia M Lowe1,2. Show Affiliations » 1. Department of Dermatology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. 2. University of Sydney, Sydney, New South Wales, Australia.
Abstract
Entities: Chemical
Mesh： See more » Erlotinib Hydrochloride/therapeutic useHumansKeratin-16Keratins/geneticsKeratoderma, Palmoplantar/diagnosisKeratoderma, Palmoplantar/drug therapyMutationPedigree
Substances： See more » Keratin-16KeratinsErlotinib Hydrochloride
Year: 2022 PMID： 34985526 DOI： 10.1001/jamadermatol.2021.5302
Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282